收稿日期: 2022-03-02
网络出版日期: 2022-08-17
基金资助
上海长征医院创新型临床研究项目(2020YLCYJ-Y04)
牟兴, 叶倩仪, 卢红娟, 徐沪济, 吴歆 . 季节变化对风湿病发病机制及病情活动的影响[J]. 诊断学理论与实践, 2022 , 21(03) : 304 -311 . DOI: 10.16150/j.1671-2870.2022.03.003
| [1] | Duarte-García A, Fang H, To CH, et al. Seasonal variation in the activity of systemic lupus erythematosus[J]. J Rheumatol, 2012, 39(7):1392-1398. |
| [2] | Szeto CC, Mok HY, Chow KM, et al. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong[J]. J Rheumatol, 2008, 35(6):1031-1037. |
| [3] | Meza-Meza MR, Muñoz-Valle JF, Ruiz-Ballesteros AI, et al. Association of high calcitriol serum levels and its hydroxylation efficiency ratio with disease risk in SLE patients with vitamin D deficiency[J]. J Immunol Res, 2021, 2021:2808613. |
| [4] | Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?[J]. Ann Rheum Dis, 2010, 69(6):1155-1157. |
| [5] | Robeva R, Tanev D, Kirilov G, et al. Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report[J]. Balkan Med J, 2013, 30(3):273-276. |
| [6] | Medrano-Campillo P, Sarmiento-Soto H, álvarez-Sánchez N, et al. Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients[J]. J Pineal Res, 2015, 58(2):219-226. |
| [7] | Sanders CJ, Van Weelden H, Kazzaz GA, et al. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol[J]. Br J Dermatol, 2003, 149(1):131-137. |
| [8] | Bengtsson AA, Rylander L, Hagmar L, et al. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden[J]. Rheumatology (Oxford), 2002, 41(5):563-571. |
| [9] | Visser E, Milne D, Collacott I, et al. The epidemiology of infectious mononucleosis in Northern Scotland: a decrea-sing incidence and winter peak[J]. BMC Infect Dis, 2014, 14:151. |
| [10] | Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up[J]. Br Med J, 1973, 2(5858):96-100. |
| [11] | Fleming A, Crown JM, Corbett M. Early rheumatoid di-sease. I. Onset[J]. Ann Rheum Dis, 1976, 35(4):357-360. |
| [12] | de Rooy DP, Andersson ML, Knevel R, et al. Does the season at symptom onset influence the long-term severity of radiographic joint destruction in rheumatoid arthritis?[J]. Ann Rheum Dis, 2012, 71(12):2055-2056. |
| [13] | Iikuni N, Nakajima A, Inoue E, et al. What′s in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity[J]. Rheumatology (Oxford), 2007, 46(5):846-848. |
| [14] | Mori H, Sawada T, Nishiyama S, et al. Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis[J]. BMC Musculoskelet Disord, 2019, 20(1):30. |
| [15] | Rozin A, Balbir-Gurman A, Schapira D. Seasonal distribution of relapse onset in rheumatoid arthritis and spondyloarthropathy: the possible effect of the solar factor[J]. Clin Exp Rheumatol, 2003, 21(2):161-169. |
| [16] | Arkema EV, Hart JE, Bertrand KA, et al. Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses′ Health Study[J]. Ann Rheum Dis, 2013, 72(4):506-511. |
| [17] | McGrath H Jr, Smith JL, Bak E, et al. Ultraviolet-A light in the treatment of rheumatoid arthritis[J]. Clin Exp Rheumatol, 1987, 5(4):323-328. |
| [18] | Fouani M, Basset CA, Mangano GD, et al. Heat shock proteins alterations in rheumatoid arthritis[J]. Int J Mol Sci, 2022, 23(5):2806. |
| [19] | Huang MN, Yu H, Moudgil KD. The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal[J]. Semin Arthritis Rheum, 2010, 40(2):164-175. |
| [20] | Lin J, Liu J, Davies ML, et al. Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis[J]. PLoS One, 2016, 11(1):e0146351. |
| [21] | Cutolo M, Otsa K, Laas K, et al. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe[J]. Clin Exp Rheumatol, 2006, 24(6):702-704. |
| [22] | Attar SM. Vitamin D deficiency in rheumatoid arthritis. Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia[J]. Saudi Med J, 2012, 33(5):520-525. |
| [23] | Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, et al. Vitamin D and rheumatoid arthritis[J]. Ther Adv Endocrinol Metab, 2012, 3(6):181-187. |
| [24] | Senior BW, Anderson GA, Morley KD, et al. Evidence that patients with rheumatoid arthritis have asymptomatic ′non-significant′ Proteus mirabilis bacteriuria more frequently than healthy controls[J]. J Infect, 1999, 38(2):99-106. |
| [25] | Auger I, Roudier J. A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4[J]. J Clin Invest, 1997, 99(8):1818-1822. |
| [26] | van Setten G, Labetoulle M, Baudouin C, et al. Evidence of seasonality and effects of psychrometry in dry eye di-sease[J]. Acta Ophthalmol, 2016, 94(5):499-506. |
| [27] | Rantanen II, Tenovuo JO, Pienihäkkinen K, et al. Seasonal variation in dry mouth symptoms of Sjögren′s syndrome patients: a clinical follow-up study[J]. Clin Exp Rheumatol, 2003, 21(5):682. |
| [28] | Müller K, Oxholm P, Sørensen OH, et al. Abnormal vitamin D3 metabolism in patients with primary Sjögren′s syndrome[J]. Ann Rheum Dis, 1990, 49(9):682-684. |
| [29] | Agmon-Levin N, Kivity S, Tzioufas AG, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren′s syndrome[J]. J Autoimmun, 2012, 39(3):234-239. |
| [30] | Erten Š, Šahin A, Altunoğlu A, et al. Comparison of plasma vitamin D levels in patients with Sjögren′s syndrome and healthy subjects[J]. Int J Rheum Dis, 2015, 18(1):70-75. |
| [31] | Igoe A, Scofield RH. Autoimmunity and infection in Sjögren′s syndrome[J]. Curr Opin Rheumatol, 2013, 25(4):480-487. |
| [32] | Kivity S, Arango MT, Ehrenfeld M, et al. Infection and autoimmunity in Sjögren′s syndrome: a clinical study and comprehensive review[J]. J Autoimmun, 2014, 51:17-22. |
| [33] | Pasoto SG, Natalino RR, Chakkour HP, et al. EBV reactivation serological profile in primary Sjögren′s syndrome: an underlying trigger of active articular involvement?[J]. Rheumatol Int, 2013, 33(5):1149-1157. |
| [34] | Watson HR, Robb R, Belcher G, et al. Seasonal variation of Raynaud′s phenomenon secondary to systemic sclerosis[J]. J Rheumatol, 1999, 26(8):1734-1737. |
| [35] | Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud′s phenomenon: a 5 region comparison[J]. J Rheumatol, 1997, 24(5):879-889. |
| [36] | Emmanuel G, Saroja D, Gopinathan K, et al. Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis[J]. Chest, 1976, 69(2 Suppl):304-307. |
| [37] | Vacca A, Cormier C, Piras M, et al. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis[J]. J Rheumatol, 2009, 36(9):1924-1929. |
| [38] | Seriolo B, Molfetta L, Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis[J]. Clin Rheumatol, 2011, 30(3):445-446. |
| [39] | Zerr P, Vollath S, Palumbo-Zerr K, et al. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis[J]. Ann Rheum Dis, 2015, 74(3):e20. |
| [40] | Usategui A, Criado G, Del Rey MJ, et al. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma[J]. Arch Dermatol Res, 2014, 306(8):757-761. |
| [41] | Kotulska A, Brzezinska-Wcislo L, Kucharz EJ. Circadian profile of serum melatonin in patients with systemic sclerosis[J]. Clin Exp Rheumatol, 2005, 23(5):728-729. |
| [42] | Dang H, Dauphinée MJ, Talal N, et al. Serum antibody to retroviral gag proteins in systemic sclerosis[J]. Arthritis Rheum, 1991, 34(10):1336-1337. |
| [43] | Neidhart M, Kuchen S, Distler O, et al. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis[J]. Arthritis Rheum, 1999, 42(2):389-392. |
| [44] | Åkerblom A, Helmersson-Karlqvist J, Weitoft T, et al. Seasonal variations of urate in a Swedish adult population[J]. Clin Rheumatol, 2017, 36(7):1595-1598. |
| [45] | Ahn H, Lee G, Lee GS. Lower temperatures exacerbate NLRP3 inflammasome activation by promoting monoso-dium urate crystallization, causing gout[J]. Cells, 2021, 10(8):1919. |
| [46] | Kardeš S. Seasonal variation in the internet searches for gout: an ecological study[J]. Clin Rheumatol, 2019, 38(3):769-775. |
| [47] | Sugimoto R, Watanabe H, Ikegami K, et al. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism[J]. Kidney Int, 2017, 91(3):658-670. |
| [48] | Ponvilawan B, Charoenngam N, Ungprasert P. Primary hyperparathyroidism is associated with a higher level of serum uric acid: a systematic review and meta-analysis[J]. Int J Rheum Dis, 2020, 23(2):174-180. |
| [49] | He YS, Wang GH, Wu Q, et al. The relationship between ambient air pollution and hospitalizations for gout in a humid subtropical region of china[J]. J Inflamm Res, 2021, 14:5827-5835. |
| [50] | Ryu HJ, Seo MR, Choi HJ, et al. Particulate matter (PM 10) as a newly identified environmental risk factor for acute gout flares: a time-series study[J]. Joint Bone Spine, 2021, 88(2):105108. |
/
| 〈 |
|
〉 |
